BK vs INTS
The Bank of New York Mellon Corporation (BK) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported BK revenue for 2025-12-31 was $20.08B. Net income was $5.55B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. BK currently screens at market cap $94.14B and trailing P/E 17.0.
INTS does not have a complete income-statement cache yet.
BK currently screens at market cap $94.14B and trailing P/E 17.0. INTS currently screens at market cap $7.7M.
Not investment advice. Open the BK and INTS stock pages for the full models.
Not investment advice.